CD274 and central nervous system cancer: The experimental results indicated that FDX1 silencing-induced inhibitions of cell invasion and migration were associated with inactivation of the NOD-like receptor signaling pathway (via regulation of PD-L1 expression); this provided valuable insights into the role of FDX1 in the progression of glioma.